These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20955906)

  • 1. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
    Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
    BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Primer for Primary Care Physicians Managing Neurogenic Bladder Patients.
    Atiemo HO; Stoffel JT
    Urol Clin North Am; 2024 May; 51(2):305-311. PubMed ID: 38609202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenic Bladder: A Complex Puzzle with Multiple Pieces.
    Stoffel JT
    Urol Clin North Am; 2024 May; 51(2):xvii-xix. PubMed ID: 38609205
    [No Abstract]   [Full Text] [Related]  

  • 4. Classification of multiple sclerosis women with voiding dysfunction using machine learning: Is functional connectivity or structural connectivity a better predictor?
    Tran K; Salazar BH; Boone TB; Khavari R; Karmonik C
    BJUI Compass; 2023 May; 4(3):277-284. PubMed ID: 37025479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is EDSS Enough to Predict Risk of Upper Urinary Tract Damage in Patients with Multiple Sclerosis?
    Stritt K; Lucca I; Roth B; Grilo N
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurogenic Bladder in Dogs, Cats and Humans: A Comparative Review of Neurological Diseases.
    Gernone F; Uva A; Cavalera MA; Zatelli A
    Animals (Basel); 2022 Nov; 12(23):. PubMed ID: 36496754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Analysis of Brain Footprints in Multiple Sclerosis Females With Detrusor Sphincter Dyssynergia: A Concurrent Urodynamic and Functional Magnetic Resonance Imaging Study.
    Tran K; Hubbard L; Karmonik C; Boone TB; Khavari R
    Int Neurourol J; 2022 Feb; 26(Suppl 1):S38-46. PubMed ID: 34856727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive, Individualized Cortical Modulation Using Transcranial Rotating Permanent Magnet Stimulator for Voiding Dysfunction in Women with Multiple Sclerosis: A Pilot Trial.
    Khavari R; Tran K; Helekar SA; Shi Z; Karmonik C; Rajab H; John B; Jalali A; Boone T
    J Urol; 2022 Mar; 207(3):657-668. PubMed ID: 34694911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods.
    Lane GI; Mao-Draayer Y; Barboglio-Romo P; Clemens JQ; Gupta P; Dunn R; Qin Y; Cameron AP; Stoffel JT
    BMC Urol; 2020 May; 20(1):58. PubMed ID: 32460741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Bladder Dysfunction and Falls in People with Relapsing-Remitting Multiple Sclerosis.
    Zelaya JE; Murchison C; Cameron M
    Int J MS Care; 2017; 19(4):184-190. PubMed ID: 28835742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.
    Aharony SM; Lam O; Corcos J
    Can Urol Assoc J; 2017; 11(1-2):61-64. PubMed ID: 28443147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms.
    Tracey JM; Stoffel JT
    Investig Clin Urol; 2016 Nov; 57(6):377-383. PubMed ID: 27847911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies.
    Stoffel JT
    Transl Androl Urol; 2016 Feb; 5(1):127-35. PubMed ID: 26904418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic Dysregulation in Multiple Sclerosis.
    Pintér A; Cseh D; Sárközi A; Illigens BM; Siepmann T
    Int J Mol Sci; 2015 Jul; 16(8):16920-52. PubMed ID: 26213927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment.
    Akkoç Y; Ersöz M; Yüceyar N; Tunç H; Köklü K; Yoldaş TK; Dönmez Ü; Uzunköprü C; Alemdaroğlu E; Bilen Ş; Emre U; Özdolap Ş; Tuncay E; Yücesan C; Gök H; Ercan MB; Uygunol K; Koçer B; Zinnuroğlu M;
    J Spinal Cord Med; 2016; 39(2):229-33. PubMed ID: 25936385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
    Adli Oel Y; Corcos J
    Can Urol Assoc J; 2014 Jan; 8(1-2):E61-7. PubMed ID: 24454606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conceptualization and development of a patient-reported neurogenic bladder symptom score.
    Welk B; Morrow SA; Madarasz W; Potter P; Sequeira K
    Res Rep Urol; 2013; 5():129-37. PubMed ID: 24400244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of the neurogenic bladder for multiple sclerosis patients.
    Stoffel JT
    Urol Clin North Am; 2010 Nov; 37(4):547-57. PubMed ID: 20955906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis and the neurogenic bladder.
    Rashid TM; Hollander JB
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):615-29. PubMed ID: 9894113
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.